Cytogenetic risk score maintains its prognostic significance in AML patients with detectable measurable residual disease undergoing transplantation in remission: on behalf of the ALWP / EBMT
Nagler, Arnon, Labopin, Myriam, Canaani, Jonathan, Niittyvuopio, Riitta, Socié, Gerard, Kröger, Nicolaus, ItälaâRemes, Maija, YakoubâAgha, Ibrahim, LabussièreâWallet, Hélène, GallegoâHerJournal:
American Journal of Hematology
DOI:
10.1002/ajh.25905
Date:
June, 2020
File:
PDF, 1.25 MB
2020